Biologic Drugs With Mechanism of Action: CD52-directed Antibody Interactions
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: CD52-directed Antibody Interactions
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 2001-05-07 | ⤷ Get Started Free | ⤷ Get Started Free |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 2001-05-07 | 5,545,403 | ⤷ Get Started Free |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 2001-05-07 | 5,545,405 | ⤷ Get Started Free |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 2001-05-07 | 5,654,403 | ⤷ Get Started Free |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 2001-05-07 | 5,846,534 | ⤷ Get Started Free |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 2001-05-07 | 6,290,961 | ⤷ Get Started Free |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
